Skip to main content

Bryan Reasons

Executive Vice President and Interim Chief Financial Officer

Bryan Reasons is the Executive Vice President and Interim Chief Financial Officer, with executive responsibility for the global finance function.

Prior to joining Mallinckrodt in March 2019, Mr. Reasons served as Senior Vice President and Chief Financial Officer of Amneal Pharmaceuticals, Inc., from May 2018 until January 2019, and as Senior Vice President, Finance and Chief Financial Officer of Impax Laboratories, Inc., from December 2012 to May 2018. Mr. Reasons previously served as Impax’s Acting Chief Financial Officer and its Vice President, Finance. Prior to joining Impax in January 2012, he held various finance management positions at Cephalon, Inc. (2005-2012), E. I. Du Pont De Nemours and Company (2003 to 2005), and PricewaterhouseCoopers LLP (1993-2003).

Mr. Reasons previously served as an independent board director and audit committee chair for both Aclaris Therapeutics, Inc. (2018-2024) and Societal CDMO, Inc., formerly Recro Pharma, Inc. (2017-2024).